Compliance Certificate under Regulation 74(5) of the SEBI (Depositories and Participants ) Regulations, 2018, for 3rd Quarter ended December 31, 2025 of FY 2025-26.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Amwill Health Care has submitted a routine quarterly compliance certificate to BSE under SEBI's Regulation 74(5). The certificate was issued by the company's Registrar and Transfer Agent, Bigshare Services Private Limited, and covers the third quarter of FY 2025-26 (October to December 2025). It confirms that no shareholders made any requests to convert their physical share certificates into demat form or vice versa during this quarter. The certificate was signed on January 8, 2026, and submitted to the exchange on January 10, 2026, by the Company's Secretary Anshu Anshuman. This is a standard regulatory filing required every quarter from listed companies.
This is a routine compliance filing with no material impact on the stock price or shareholders. It simply confirms there were no share conversion (demat/remat) requests during the quarter, indicating normal shareholding activity.